SEC Form 4 · accession 0001179110-16-018949
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ganesh Venkataraman Kaundinya
Officer — Senior V.P., Research
Period of report
Feb 9, 2016
Accepted (ET)
Feb 11, 2016 · 2:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 9, 2016 | A | 18,900 | $0.00 | A | 406,005 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $10.83 | Feb 9, 2016 | A | 37,800 | A | Feb 9, 2017 | Feb 9, 2026 | Common Stock | 37,800 | 37,800 | D |
Explanation of responses
- F1Represents 18,900 shares of restricted common stock, $0.0001 par value per share, awarded pursuant to the Company's 2013 Stock Incentive Plan, and subject to a restricted stock agreement to be entered between the Company and Mr. Kaundinya. Pursuant to the restricted stock agreement, 25% of the shares of restricted Common Stock shall vest on February 9, 2017 and an additional 6.25% of the shares of restricted Common Stock shall vest at the end of each three-month period thereafter.
- F2Represents options granted by the issuer pursuant to the issuer's 2013 Stock Incentive Plan. Subject to certain criteria such options vest with 25% shares of such option one year following the date of grant and 6.25% shares of such option shall vest at the end of each three-month period thereafter.